FDA Guidance Calls for Three-Step Mitigation Strategy for Nitrosamines

The FDA urges API and drug manufacturers to adopt a three-step mitigation strategy to prevent high levels of nitrosamine impurities, in a new revised guidance.
Source: Drug Industry Daily